Zobrazeno 1 - 10
of 42
pro vyhledávání: '"R. F. Lemanske"'
Autor:
Wayne J. Morgan, Michael D. Cabana, Cori L. Daines, W. A. Gower, Wanda Phipatanakul, Rachel G. Robison, Stephen C. Lazarus, Harsha Vardhan Hampasandra Madan Kumar, Jyothi Marbin, Fernando D. Martinez, Hengameh H. Raissy, James N. Moy, Jonathan M. Gaffin, Michael E. Wechsler, Elliot Israel, Kristie R. Ross, Shannon Thyne, Ngoc P. Ly, Ross Myers, Susan J. Boehmer, R. F. Lemanske, Stephen P. Peters, Ian M. Paul, Kathryn V. Blake, Deborah A. Gentile, Michael O. Daines, Sachin N. Baxi, Fernando Holguin, John J. Lima, Avraham Beigelman, William J. Sheehan, C. A. Sorkness, J. T. Olin, Stanley J. Szefler, M. Benson, Leonard B. Bacharier, D. J. Jackson, Ronina A. Covar, Jason E. Lang, Anne M. Fitzpatrick, James F. Chmiel, Jacqueline A. Pongracic, David T. Mauger
Publikováno v:
The New England journal of medicine, vol 375, iss 7
BackgroundStudies have suggested an association between frequent acetaminophen use and asthma-related complications among children, leading some physicians to recommend that acetaminophen be avoided in children with asthma; however, appropriately des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa9a79799ee7b40f329ac7c6203ca21
https://escholarship.org/uc/item/31v6d83t
https://escholarship.org/uc/item/31v6d83t
Autor:
Y Wang, C Tong, Z Wang, D Mauger, K G Tantisira, E Israel, S J Szefler, V M Chinchilli, H A Boushey, S C Lazarus, R F Lemanske, R Wu
Publikováno v:
Wang, Y; Tong, C; Wang, Z; Wang, Z; Mauger, D; Tantisira, KG; et al.(2015). Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma. Pharmacogenomics Journal. doi: 10.1038/tpj.2014.83. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/44r1f8tr
The pharmacogenomics journal, vol 15, iss 5
The pharmacogenomics journal, vol 15, iss 5
© 2015 Macmillan Publishers Limited Asthma is a chronic lung disease that has a high prevalence. The therapeutic intervention of this disease can be made more effective if genetic variability in patients’ response to medications is implemented. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113b0c50a5272709d37d0e5c30328db5
https://europepmc.org/articles/PMC6156797/
https://europepmc.org/articles/PMC6156797/
Autor:
R. F. Lemanske
Publikováno v:
JAMA: The Journal of the American Medical Association. 278:1855-1873
Publikováno v:
Chest. 101:385S-388
Autor:
K T, Sullivan Dillie, C J, Tisler, D F, Dasilva, T E, Pappas, K A, Roberg, K T, Carlson-Dakes, M D, Evans, L A, Rosenthal, R E, Gangnon, J E, Gern, R F, Lemanske
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 38(2)
Several studies have evaluated the associations between cord blood cellular responses and atopic diseases in children, but the results of these studies are inconsistent. Variations in blood processing factors and maternal and infant characteristics a
Publikováno v:
Asthma Prevention ISBN: 9780429116964
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85ba9a7eb4b0f881e10802ca791d6cd0
https://doi.org/10.1201/b14148-5
https://doi.org/10.1201/b14148-5
Autor:
R F, Lemanske
Publikováno v:
Pediatric pulmonology. Supplement. 21
Several early events and risk factors are associated with the development of childhood asthma. Two significant risk factors are viral lower respiratory tract infections and atopy. Studies suggest that imbalances in TH1/TH2 cytokine responses in relat
Autor:
R F, Lemanske, C A, Sorkness, E A, Mauger, S C, Lazarus, H A, Boushey, J V, Fahy, J M, Drazen, V M, Chinchilli, T, Craig, J E, Fish, J G, Ford, E, Israel, M, Kraft, R J, Martin, S A, Nachman, S P, Peters, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Inhaled long-acting beta(2)-agonists improve asthma control when added to inhaled corticosteroid (ICS) therapy.To determine whether ICS therapy can be reduced or eliminated in patients with persistent asthma after adding a long-acting beta(2)-agonist
Autor:
S C, Lazarus, H A, Boushey, J V, Fahy, V M, Chinchilli, R F, Lemanske, C A, Sorkness, M, Kraft, J E, Fish, S P, Peters, T, Craig, J M, Drazen, J G, Ford, E, Israel, R J, Martin, E A, Mauger, S A, Nachman, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Long-acting beta(2)-agonists are prescribed for patients with persistent asthma and are sometimes used without inhaled corticosteroids (ICSs). No evidence exists, however, to support their use as monotherapy in adults with persistent asthma.To examin
Autor:
E, Israel, J M, Drazen, S B, Liggett, H A, Boushey, R M, Cherniack, V M, Chinchilli, D M, Cooper, J V, Fahy, J E, Fish, J G, Ford, M, Kraft, S, Kunselman, S C, Lazarus, R F, Lemanske, R J, Martin, D E, McLean, S P, Peters, E K, Silverman, C A, Sorkness, S J, Szefler, S T, Weiss, C N, Yandava
Publikováno v:
International archives of allergy and immunology. 124(1-3)
Regular use of inhaled beta-adrenergic agonists may have adverse effects in some asthma patients. Polymorphisms of the beta(2)-adrenergic receptor (beta(2)-AR) can affect its regulation; however, results of smaller studies of the effects of such poly